内分泌科

订阅

MedSci主页 / 所有栏目 / 内分泌科

联糖日|中国糖尿病指南共识数据一览

2016-11-14 MedSci MedSci原创

联糖日糖尿病
关注

每年的11月14日，是“联合国糖尿病日”（前身是“世界糖尿病日”）。今年国际糖尿病联盟（IDF）公布的主题是“EyesonDiabetes（着眼糖尿病）”，呼吁全球人民一起关注糖尿病，做好糖尿病筛查，联手抗击糖尿病。2015年，国际糖尿病联合会发布的数据显示，全球大约每6秒就有1个糖尿病患者死亡。中国成人糖尿病患者数量排在各国之首，超过1亿。据世卫组织预测，到2030年，糖尿病将成为第七项主要死亡


每年的11月14日，是“联合国糖尿病日”（前身是“世界糖尿病日”）。今年国际糖尿病联盟（IDF）公布的主题是“Eyes on Diabetes（着眼糖尿病）”，呼吁全球人民一起关注糖尿病，做好糖尿病筛查，联手抗击糖尿病。2015年，国际糖尿病联合会发布的数据显示，全球大约每6秒就有1个糖尿病患者死亡。中国成人糖尿病患者数量排在各国之首，超过1亿。据世卫组织预测，到2030年，糖尿病将成为第七项主要死亡原因。 

糖尿病逐渐成为威胁人类健康的主要慢性疾病，给人们带来了沉重的健康和经济负担。今天是联合国糖尿病，梅斯医学编辑对2016年更新的糖尿病指南进行了汇总，选出最新的、关注度最高的6部中文指南与大家分享。 我们一直在战胜糖尿病的路上，从未停止。

 

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=157542, encodeId=a35315e54232, content=控制血糖, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636c1980460, createdName=小子慢慢来, createdTime=Tue Nov 22 23:36:24 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156576, encodeId=7a511565e601, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Nov 18 11:09:48 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156268, encodeId=f69e1562687c, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Nov 17 07:47:22 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155745, encodeId=db2e155e45c2, content=指南多的多, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Mon Nov 14 19:48:44 CST 2016, time=2016-11-14, status=1, ipAttribution=)]
    2016-11-22 小子慢慢来

    控制血糖

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=157542, encodeId=a35315e54232, content=控制血糖, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636c1980460, createdName=小子慢慢来, createdTime=Tue Nov 22 23:36:24 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156576, encodeId=7a511565e601, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Nov 18 11:09:48 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156268, encodeId=f69e1562687c, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Nov 17 07:47:22 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155745, encodeId=db2e155e45c2, content=指南多的多, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Mon Nov 14 19:48:44 CST 2016, time=2016-11-14, status=1, ipAttribution=)]
    2016-11-18 李东泽

    这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=157542, encodeId=a35315e54232, content=控制血糖, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636c1980460, createdName=小子慢慢来, createdTime=Tue Nov 22 23:36:24 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156576, encodeId=7a511565e601, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Nov 18 11:09:48 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156268, encodeId=f69e1562687c, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Nov 17 07:47:22 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155745, encodeId=db2e155e45c2, content=指南多的多, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Mon Nov 14 19:48:44 CST 2016, time=2016-11-14, status=1, ipAttribution=)]
    2016-11-17 李东泽

    很好，不错，以后会多学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=157542, encodeId=a35315e54232, content=控制血糖, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636c1980460, createdName=小子慢慢来, createdTime=Tue Nov 22 23:36:24 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156576, encodeId=7a511565e601, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Nov 18 11:09:48 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156268, encodeId=f69e1562687c, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Thu Nov 17 07:47:22 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155745, encodeId=db2e155e45c2, content=指南多的多, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Mon Nov 14 19:48:44 CST 2016, time=2016-11-14, status=1, ipAttribution=)]
    2016-11-14 Peter程

    指南多的多

    0